Completed PHASE4 INTERVENTIONAL NCT00251069

Glucosamine Sulphate and Increased Level of Blood Cholesterol

Glucosamine Sulphate and Hypercholesterolaemia

Sponsor: Pharma Nord

Updated 4 times since 2017 Last updated: Nov 7, 2005 Started: Apr 30, 2005 Completion: Aug 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00251069, this PHASE4 trial focuses on Osteoarthritis and remains completed. Sponsored by Pharma Nord, it has been updated 4 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pharma Nord
Slidgigtinstituttet

Data source: Slidgigtinstituttet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ishøj, Denmark